As the COVID-19 cases were gradually declining and the Indian government had just lifted restrictions on restrictions, a case of infection caused by the recombinant XE variant of the COVID-19 virus.
Where was the first case of the recombinant XE variant detected?
The Brihanmumbai Municipal Corporation (BMC) has confirmed the detection of a COVID case in Mumbai.
Only a few days before, the World Health Organization (WHO) had warned us about thisto new strain which, he said, is the recombination of strains BA.1 and BA.2 of the Omicron super spreader variant.
According to the WHO prediction, this recombinant can spread much faster than Omicron. We still remember how Omicron, the successor to the Delta strain, took over his ancestor in a very short time.
Although hospitalization cases were minor by Omicron’s infection, he infected a large number of people.
So alarming was Omicron transmission rate which led the third wave of COVID-19 in early 2022 despite vaccination efforts around the world.
How many cases of XE have been reported so far?
Before the Mumbai case, 637 cases of XE infection were reported.
“A total of 637 XE cases have been confirmed so far. A recombinant of Ómicron BA.1 and BA.2, in the UK. The first of these has a sample date of January 19, 2022.” Says an October 2021 report from the UK Health Security Agency; this report was updated on March 25.
Will it be aggressive?
“This particular recombinant, XE, has shown a variable growth rate and we cannot yet confirm if it has a true growth advantage. At this time, there is not enough evidence to draw conclusions about the transmissibility, severity, or effectiveness of the vaccine,” said Susan Hopkins, chief medical officer. Advisor, says the UK Health Security Agency.
What are the symptoms of XE-induced COVID infection?
Until now, no symptoms specific and distinct from the COVID-19 infection caused by XE have emerged. However, the common symptoms that have remained in the population since the first wave are cold, fever, headache, fatigue, weakness, muscle pain, abdominal pain and nausea.
Can vaccines protect us?
Experts have endorsed the efficacy of vaccines in protecting against the severity of COVID-19 infection. Until now, the majority of the population in the world has received the first vaccine. The booster dose or the precautionary dose is being given to the elderly.
Experts emphasize the booster dose so that the body’s immune system remains alert to the pathogen and protects the body in the long term.
Foods that can help control Endometriosis
5 applications that cannot be missing from the smartphone of the successful doctor
7 Habits ALL Highly Healthy Doctors Have